Abstract
Background
Frequent incidence of futile recanalization decreases the benefit of endovascular treatment (EVT) in acute ischemic stroke. We hypothesized that the inflammation and immune response after ischemic are associated with futile recanalization. We aimed to investigate the correlation of admission systemic immune-inflammation index (SII) with futile recanalization post EVT.
Methods
Patients with successful recanalization (modified Thrombolysis in Cerebral Ischemia angiographic score 2b–3) and maintained artery recanalized after 24 h of EVT were chosen from a prospective nationwide registry study. Futile recanalization was defined as a poor functional outcome (modified Rankin Scale score 3–6) at 90 days, irrespective of a successful recanalization. At admission, SII was calculated as (platelet count × neutrophil count)/lymphocyte count/100. Logistic regression analysis helped to test the relationship of SII with futile recanalization.
Results
Among the 1,002 patients included, futile recanalization occurred in 508 (50.70%). No matter whether tested as quartiles or continuous variables, SII was significantly associated with futile recanalization (P < 0.05), and for every one standard deviation increase of SII, the risk of futile recanalization elevated by 22.3% (odds ratio 1.223, 95% confidence interval 1.053–1.444, P = 0.0093). Moreover, no significant interactions could be observed between SII or SII quartiles and age, baseline National Institutes of Health Stroke Scale scores, onset-to-recanalization time, and modified Thrombolysis in Cerebral Ischemia angiographic scores (all P for interaction > 0.05).
Conclusions
Early SII elevation was associated with an increased risk of futile recanalization among patients with EVT. Our results indicated that therapeutic drug targeting hyperreactive immune-inflammation response might be helpful for reducing the incidence of futile recanalization.
Similar content being viewed by others
Source of Support
Zhongrong Miao reports grants from the National Key Research and Development Program of China (2016 YFC1301500). Anxin Wang reports grants from National Key Research and Development Program of China (2022YFC3600600 and 2022YFC3600603), Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University (CCMU2022ZKYXZ009), and Beijing Natural Science Foundation Haidian original innovation joint fund (L222123). Wei Yue reports grants from Tianjin Health Commission Science and Technology Projects (TJWJ2021QN061 and ZC20134), and Tianjin Key Medical Discipline (Specialty) Construction Project (No. TJYXZDXK-052B).
References
Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31. https://doi.org/10.1016/S0140-6736(16)00163-X.
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50(12):e344–418. https://doi.org/10.1161/STR.0000000000000211.
Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316(12):1279–88. https://doi.org/10.1001/jama.2016.13647.
Hussein HM, Saleem MA, Qureshi AI. Rates and predictors of futile recanalization in patients undergoing endovascular treatment in a multicenter clinical trial. Neuroradiology. 2018;60(5):557–63. https://doi.org/10.1007/s00234-018-2016-2.
El Amki M, Wegener S. Improving cerebral blood flow after arterial recanalization: a novel therapeutic strategy in stroke. Int J Mol Sci. 2017. https://doi.org/10.3390/ijms18122669.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708–18. https://doi.org/10.1056/NEJMoa1713973.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21. https://doi.org/10.1056/NEJMoa1706442.
Deng G, Xiao J, Yu H, et al. Predictors of futile recanalization after endovascular treatment in acute ischemic stroke: a meta-analysis. J Neurointerv Surg. 2022;14(9):881–5. https://doi.org/10.1136/neurintsurg-2021-017963.
Groot AE, Treurniet KM, Jansen IGH, et al. Endovascular treatment in older adults with acute ischemic stroke in the MR CLEAN Registry. Neurology. 2020;95(2):e131–9. https://doi.org/10.1212/WNL.0000000000009764.
Yang J, Jin Z, Song J, et al. Futile recanalization after endovascular treatment in patients with acute basilar artery occlusion. Neurosurgery. 2022. https://doi.org/10.1227/neu.0000000000002313.
El Amki M, Gluck C, Binder N, et al. Neutrophils obstructing brain capillaries are a major cause of no-reflow in ischemic stroke. Cell Rep. 2020;33(2): 108260. https://doi.org/10.1016/j.celrep.2020.108260.
Laredo C, Rodriguez A, Oleaga L, et al. Adjunct thrombolysis enhances brain reperfusion following successful thrombectomy. Ann Neurol. 2022;92(5):860–70. https://doi.org/10.1002/ana.26474.
Renu A, Millan M, San Roman L, et al. Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial. JAMA. 2022;327(9):826–35. https://doi.org/10.1001/jama.2022.1645.
del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 1991;22(10):1276–83. https://doi.org/10.1161/01.str.22.10.1276.
Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke. 1994;25(9):1847–53. https://doi.org/10.1161/01.str.25.9.1847.discussion53-4.
Kloner RA, King KS, Harrington MG. No-reflow phenomenon in the heart and brain. Am J Physiol Heart Circ Physiol. 2018;315(3):H550–62. https://doi.org/10.1152/ajpheart.00183.2018.
Hallenbeck JM, Dutka AJ, Tanishima T, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke. 1986;17(2):246–53. https://doi.org/10.1161/01.str.17.2.246.
Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23(9):1367–79. https://doi.org/10.1161/01.str.23.9.1367.
Obrenovitch TP, Hallenbeck JM. Platelet accumulation in regions of low blood flow during the postischemic period. Stroke. 1985;16(2):224–34. https://doi.org/10.1161/01.str.16.2.224.
Mandel J, Casari M, Stepanyan M, Martyanov A, Deppermann C. Beyond hemostasis: platelet innate immune interactions and thromboinflammation. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23073868.
Jia B, Ren Z, Mokin M, et al. Current status of endovascular treatment for acute large vessel occlusion in china: a real-world nationwide registry. Stroke. 2021;52(4):1203–12. https://doi.org/10.1161/STROKEAHA.120.031869.
Geraghty JR, Lung TJ, Hirsch Y, et al. Systemic immune-inflammation index predicts delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2021;89(6):1071–9. https://doi.org/10.1093/neuros/nyab354.
Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. https://doi.org/10.1186/s12974-019-1516-2.
Yemisci M, Gursoy-Ozdemir Y, Vural A, et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009;15(9):1031–7. https://doi.org/10.1038/nm.2022.
Peppiatt CM, Howarth C, Mobbs P, Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature. 2006;443(7112):700–4. https://doi.org/10.1038/nature05193.
Ter Schiphorst A, Charron S, Hassen WB, et al. Tissue no-reflow despite full recanalization following thrombectomy for anterior circulation stroke with proximal occlusion: a clinical study. J Cereb Blood Flow Metab. 2021;41(2):253–66. https://doi.org/10.1177/0271678X20954929.
Ng FC, Churilov L, Yassi N, et al. Prevalence and significance of impaired microvascular tissue reperfusion despite macrovascular angiographic reperfusion (no-reflow). Neurology. 2022;98(8):e790–801. https://doi.org/10.1212/WNL.0000000000013210.
Pektezel MY, Yilmaz E, Arsava EM, Topcuoglu MA. Neutrophil-to-lymphocyte ratio and response to intravenous thrombolysis in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(7):1853–9. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.04.014.
Wang C, Zhang Q, Ji M, Mang J, Xu Z. Prognostic value of the neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis. BMC Neurol. 2021;21(1):191. https://doi.org/10.1186/s12883-021-02222-8.
Lattanzi S, Norata D, Divani AA, et al. Systemic inflammatory response index and futile recanalization in patients with ischemic stroke undergoing endovascular treatment. Brain Sci. 2021. https://doi.org/10.3390/brainsci11091164.
Huang J, Choudhri TF, Winfree CJ, et al. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke. 2000;31(12):3047–55.
Erdener SE, Tang J, Kilic K, et al. Dynamic capillary stalls in reperfused ischemic penumbra contribute to injury: a hyperacute role for neutrophils in persistent traffic jams. J Cereb Blood Flow Metab. 2021;41(2):236–52. https://doi.org/10.1177/0271678X20914179.
Chia S, Nagurney JT, Brown DF, et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2009;103(3):333–7. https://doi.org/10.1016/j.amjcard.2008.09.085.
Acknowledgements
We gratefully acknowledge all the participants, clinicians, statisticians, and laboratory and imaging technicians.
Author information
Authors and Affiliations
Contributions
GC and AW conducted the statistical analysis, interpreted the data, and drafted the manuscript. XZ, YL, XX, XT, and JL interpreted the data, and commented on the drafts. ZM performed the study. WY supervised the analysis, interpreted the data, and commented on the drafts. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of Interest
None declared.
Ethical Approval/Informed consent
This study (Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke) has been approved by the institutional review board of all the centers. The number of the approval was KY2017-048-01.
Clinical Trial Registration
ClinicalTrials.gov: NCT03370939.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, G., Wang, A., Zhang, X. et al. Systemic Immune-Inflammation Response is Associated with Futile Recanalization After Endovascular Treatment. Neurocrit Care (2024). https://doi.org/10.1007/s12028-023-01930-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12028-023-01930-y